SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,633,410 | +5.8% | 71,221 | -0.0% | 0.01% | +14.3% |
Q2 2023 | $8,159,435 | -16.9% | 71,249 | +0.0% | 0.01% | -22.2% |
Q1 2023 | $9,817,217 | +1687.3% | 71,227 | +1580.3% | 0.01% | +800.0% |
Q4 2022 | $549,290 | +16.9% | 4,239 | -0.3% | 0.00% | – |
Q3 2022 | $470,000 | +51.1% | 4,250 | +2.5% | 0.00% | – |
Q2 2022 | $311,000 | +40.1% | 4,145 | +46.0% | 0.00% | – |
Q1 2022 | $222,000 | -96.5% | 2,840 | -92.5% | 0.00% | -100.0% |
Q4 2020 | $6,424,000 | -31.3% | 37,779 | -38.6% | 0.01% | -36.4% |
Q2 2019 | $9,345,000 | +30.7% | 61,500 | +2.5% | 0.01% | +22.2% |
Q1 2019 | $7,151,000 | +5.6% | 60,000 | -3.3% | 0.01% | 0.0% |
Q4 2018 | $6,772,000 | -68.1% | 62,053 | -52.8% | 0.01% | -62.5% |
Q3 2018 | $21,247,000 | +21.6% | 131,553 | -0.5% | 0.02% | +26.3% |
Q2 2018 | $17,477,000 | +837.1% | 132,220 | +425.1% | 0.02% | +850.0% |
Q1 2018 | $1,865,000 | +88.6% | 25,178 | +41.6% | 0.00% | +100.0% |
Q4 2017 | $989,000 | -12.8% | 17,775 | -28.9% | 0.00% | 0.0% |
Q3 2017 | $1,134,000 | – | 25,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |